BA

Bikrant Amal Arya

Active Director Director DIN 08835051
DIN 08835051 First appointment Aug 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Bikrant Amal Arya

Data last updated:

Bikrant Amal Arya is a Director at Steradian Pharmaceutical Private Limited (since 2020). The company operates in Pharma.

DIN 08835051
Primary Designation Director
Industry Pharma
First Appointment 25 Aug 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Aug 20202020Active

Directorship timeline

Open interactive timeline →
Steradian Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Bikrant Amal Arya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bikrant Amal Arya

Bikrant Amal Arya currently holds 1 directorship: Steradian Pharmaceutical Private Limited (Director, since 25 Aug 2020).

Bikrant Amal Arya was first appointed on 25 Aug 2020 as Director at Steradian Pharmaceutical Private Limited.

The current boards of Bikrant Amal Arya's companies include Abhishek Ashok Kherde (Steradian Pharmaceutical Private Limited), Kapil Shankar Wath (Steradian Pharmaceutical Private Limited), Lokesh Shankar Bhujade (Steradian Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available